Common use of Scientific Publication Clause in Contracts

Scientific Publication. The JSC shall discuss the publication strategy for the publication of scientific papers, abstracts, meeting presentations and other disclosure of the results of the studies carried out under this Agreement, taking into consideration the Parties’ interest in publishing the results of the Development work to obtain recognition within the scientific community and to advance the state of scientific knowledge, and the need to protect Confidential Information, intellectual property rights and other business interests of the Parties. Zai shall provide Entasis with the opportunity to review and comment on any proposed publication that pertains to Licensed Products at least [*] prior to its intended submission for publication. Entasis shall provide Zai with its comments, if any, within [*] after the receipt of such proposed publication. Zai shall consider in good faith the comments provided by Entasis and shall comply with Entasis’s request to: (a) remove any and all Confidential Information of Entasis from such proposed publication; and (b) delay the proposed submission for a period up to [*] as may be reasonably necessary to seek patent protection for the information disclosed in the proposed publication. Entasis shall notify Zai of any proposed publication that is related to a Licensed Product and provide a copy of such publication to Zai within [*] after such proposed [ ] = Certain confidential information contained in this document, marked by brackets, is filed with the Securities and Exchange Commission pursuant to Rule 406 of the Securities Act of 1933, as amended. publication is accepted for publication. Each Party agrees to acknowledge the contribution of the other Party and its employees in all publications as scientifically appropriate.

Appears in 2 contracts

Samples: License and Collaboration Agreement (Entasis Therapeutics LTD), License and Collaboration Agreement (Entasis Therapeutics LTD)

AutoNDA by SimpleDocs

Scientific Publication. The JSC shall discuss the publication strategy for the publication of scientific papers, abstracts, meeting presentations and other disclosure of the results of the studies carried out under this Agreement, taking into consideration the Parties’ interest in publishing the results of the Development work to obtain recognition within the scientific community and to advance the state of scientific knowledge, and the need to protect Confidential Information, intellectual property rights and other business interests of the Parties. Zai shall provide Entasis with the opportunity to review and comment on any proposed publication that pertains to Licensed Products at least [********] prior to its intended submission for publication. Entasis shall provide Zai with its comments, if any, within [********] after the receipt of such proposed publication. Zai shall consider in good faith the comments provided by Entasis and shall comply with Entasis’s request to: (a) remove any and all Confidential Information of Entasis from such proposed publication; and (b) delay the proposed submission for a period up to [********] as may be reasonably necessary to seek patent protection for the information disclosed in the proposed publication. Entasis shall notify Zai of any proposed publication that is related to a Licensed Product and provide a copy of such publication to Zai within [********] after such proposed [ ] = Certain confidential information contained in this document, marked by brackets, is filed with the Securities and Exchange Commission pursuant to Rule 406 of the Securities Act of 1933, as amended. publication is accepted for publication. Each Party agrees to acknowledge the contribution of the other Party and its employees in all publications as scientifically appropriate.

Appears in 1 contract

Samples: License and Collaboration Agreement (Zai Lab LTD)

AutoNDA by SimpleDocs

Scientific Publication. The JSC JDC shall discuss the publication strategy for the publication of scientific papers, abstracts, meeting presentations and other disclosure of the results of the studies Clinical Trials carried out under this Agreement, taking into consideration (i) the Parties’ interest in publishing the results of the Development work in order to obtain recognition within the scientific community and to advance the state of scientific knowledge, and (ii) the need to protect Confidential Information, intellectual property rights and other business interests of the Parties and (iii) academic and/or governmental entities publications rights and rules (and each Parties’ obligations and undertakings in connection thereto). Zai Subject to and taking into account all applicable academic and/or governmental entities publications rights and rules (and each Parties’ obligations and undertakings in connection thereto), each Party shall provide Entasis the other Party with the opportunity to review and comment on any proposed publication that pertains to the Licensed Compounds or Licensed Products at least [*] forty-five (45) days prior to its intended submission for publication. Entasis publication and shall provide Zai with its comments, if any, within [*] after the receipt of other Party the opportunity to comment on such proposed publication. Zai Such Party shall consider in good faith the comments provided by Entasis the other Party and shall comply with Entasisthe other Party’s request to: (a) remove any and all Confidential Information of Entasis the other Party from such proposed publication; publication and (b) delay the proposed submission for a period up to [*] ninety (90) days (or any other period of time as may be reasonably necessary to seek patent protection by the other Party for the information disclosed in the proposed publication. Entasis shall notify Zai of any proposed publication that is related to a Licensed Product and provide a copy of such publication to Zai within [*] after such proposed [ ] = Certain confidential information contained in this document, marked by brackets, is filed with the Securities and Exchange Commission pursuant to Rule 406 of the Securities Act of 1933, as amended. publication is accepted for publication). Each Party agrees to acknowledge the contribution of the other Party and its the other Party’s employees in all publications publication as scientifically appropriate. No Licensed Know-How may be disclosed or published without the prior written consent of Licensor, which consent to not be unreasonably withheld.

Appears in 1 contract

Samples: Research Collaboration and License Agreement (Palisade Bio, Inc.)

Time is Money Join Law Insider Premium to draft better contracts faster.